Lung parenchyma · ESR chapter pp.120–124
Lung cancer: imaging, staging & screening
CT detects and stages; PET/CT refines N and M staging; TNM drives treatment through the multidisciplinary tumour board.
Practise this topic (2 questions)Epidemiology and imaging role
- Smoking causes ~85% of cases; about 12% of new cases occur in never-smokers, and roughly 65% arise in former or never smokers. Only ~25% survive >5 years overall.
- CT is the primary tool for detection and staging; PET/CT separates tumour from atelectasis, finds nodal/distant metastases and synchronous cancers.
TNM and the MDT
- T = tumour size/local invasion; N = nodal involvement (ipsilateral vs contralateral, hilar vs mediastinal); M = distant metastases.
- Example: tumour >7 cm + contralateral mediastinal nodes + single extrathoracic metastasis → T4 N3 M1b (8th edition).
- Multidisciplinary tumour boards improve treatment efficacy and outcomes.
Screening
- Annual low-dose CT in high-risk current/former heavy smokers lowers lung-cancer mortality; CXR screening does not.
- Limits: false positives, overdiagnosis, radiation, cost and access; VDT is a key parameter in screening follow-up.
Images for this topic
4 images